Coronary Artery Disease
Last Posted: Sep 18, 2022
- Machine Learning Algorithms for Prediction of Survival by Stress Echocardiography in Chronic Coronary Syndromes
L Cortiginai et al, J Per Med, September 16, 2022
- Personalized Medicine in Coronary Artery Disease: Where Are We in 2022?
Dmitry Shchekochikhin et al, J Per Medicine, September 1, 2022
- Broad clinical manifestations of polygenic risk for coronary artery disease in the Women’s Health Initiative
SL Clarke et al, Comm Medicine, August 25, 2022
- Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization Study.
Cupido Arjen J et al. JAMA cardiology 2022 8
- Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association
JW O'Sullivan et al, Circulation, July 18, 2022
- Association of Lipoprotein (a) in Coronary Artery Disease in Young Individuals.
Patted Aishwarya et al. The Journal of the Association of Physicians of India 2022 70(4) 11-12
- Prediction of Mortality in Coronary Artery Disease: Role of Machine Learning and Maximal Exercise Capacity.
de Souza E Silva Christina G et al. Mayo Clinic proceedings 2022
- Familial hypercholesterolaemia: a study protocol for identification and investigation of potential causes and markers of subclinical coronary artery disease in the Faroe Islands.
Borg Sanna Á et al. BMJ open 2022 12(4) e050857
- Machine learning models for prediction of adverse events after percutaneous coronary intervention.
Niimi Nozomi et al. Scientific reports 2022 12(1) 6262
- Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential.
Nakao Tetsushi et al. Science advances 2022 8(14) eabl6579
HLBS-PopOmics is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to Heart and Vascular Diseases(H), Lung Diseases(L), Blood Diseases(B), and Sleep Disorders(S)...more
- NIH Information (8)
- COVID-19 (41)
- Human Genome Epidemiologic Studies (3564)
- GWAS Studies (142)
- Human Genomics Translation/Implementation Studies (240)
- Genomic Tests Evidence Synthesis (18)
- Genomic Tests Guidelines (4)
- Tier-Classified Guidelines (1)
- Non-Genomics Precision Health (64)
- State Public Health Genomics Programs (4)
- Reviews/Commentaries (98)
- Tools/Methods (6)
- Ethical/Legal and Social Issues (ELSI) (1)
Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.